Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abcam BRD-7389, p90 Ribosomal S6 Kinase Inhibitor, Solid, 25 mg

Catalog No. 502704908
Encompass_Preferred
Change view
Click to view available options
Quantity:
25 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-270-4908 25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-270-4908 Supplier Abcam Supplier No. AB14616125MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Potent RSK inhibitor that upregulates insulin expression and exhibits reprogramming effects in terminally differentiated cells.

  • Potency: p90 ribosomal S6 kinase (RSK) inhibitor with IC50 values of 1.2 μM (RSK3), 1.5 μM (RSK1), and 2.4 μM (RSK2)
  • Biological Activity: Upregulates insulin expression in pancreatic α-cells and demonstrates reprogramming effects in terminally differentiated cells
  • Molecular Weight: 366.4 Da
  • Composition: 100% 1-Phenethylamino-3H-naphtho[1,2,3-de]quinoline-2,7-dione
  • Form: Solid
  • Storage: Store at -20°C

The product is subject to the following: Abcam Restricted Use Statement

Specifications

Target Molecule p90 Ribosomal S6 Kinase (RSK)
Substrate Properties Chemical Substrate
Shipping Condition Ambient
Form Solid
Buffer 100% 1-Phenethylamino-3H-naphtho[1,2,3-de]quinoline-2,7-dione
Content And Storage Store at -20°C.
Formulation 100% 1-Phenethylamino-3H-naphtho[1,2,3-de]quinoline-2,7-dione
Quantity 25 mg
For Use With (Application) p90 ribosomal S6 kinase inhibition
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.